Hemophilia A is being explored as a candidate for hematopoietic stem cell therapies, particularly gene therapy, due to its unique characteristics related to factor VIII activity levels Shelton (2025).
These findings highlight the importance of early intervention and ongoing research into hemophilia treatments.
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: